Study Finds Species-Specific MANF Function in Nonhuman Primates

Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a widely expressed, non-canonical neurotrophic protein in the brain. While prior studies suggest MANF can influence neuronal behavior in multiple disease contexts, its cell-type-specific functions—and why human genetic loss of MANF causes severe neurodevelopmental effects—have remained unclear. Notably, evidence from patients links MANF deficiency to microcephaly, yet conventional rodent models have not reproduced this outcome.

To resolve the species gap, researchers compared mice and non-human primates and used CRISPR/Cas9-based gene editing to reduce MANF in vivo and in primary cell cultures. By combining molecular assays, transcriptome profiling, and functional rescue experiments, the study mapped how acute MANF depletion reshapes survival signaling in astrocytes.

The central result is striking: MANF loss compromises astrocyte viability in monkeys but does not measurably affect astrocyte or neuron survival in mice. This divergence aligns with the broader observation that MANF knockout mice often show limited neurological phenotypes, whereas humans carrying MANF deletions develop profound developmental abnormalities. Together, the data support a primate-specific requirement for MANF in maintaining astrocyte integrity.

Mechanistically, the team identified a downstream signaling route mediated by leukemia inhibitory factor (LIF) and signal transducer and activator of transcription 3 (STAT3). Reduced MANF in monkey astrocytes leads to decreased LIF expression, which in turn dampens STAT3 pathway activity—creating pro-apoptotic conditions that trigger selective astrocyte death.

In contrast to mice, where this survival coupling is absent or functionally muted, primate astrocytes appear to rely on the MANF–LIF–STAT3 axis as a critical guardian signal. The study further demonstrates causality by showing that restoring LIF signaling can mitigate the apoptotic cascade initiated by MANF deficiency.

These findings position LIF as a plausible therapeutic leverage point for MANF-related neurodevelopmental disorders. More broadly, the work highlights the value of non-human primate models when studying human-relevant brain mechanisms that may not translate cleanly from rodents.

The research, titled “MANF is essential for astrocyte survival in the monkey brain,” was published in Protein & Cell. By clarifying how a conserved neurotrophic factor can operate through species-specific circuitry, the study provides a testable framework for targeted interventions aimed at preserving astrocyte survival during development.